lidocaine
Commercial- Indications
- Anesthesia
Company intelligence / Profile preview
In 2024, ODP successfully piloted its Pharmacy on Demand™ system with North Mississippi Health Services, compounding ~12,000 prefilled syringes across five FDA shortage-listed medications. The company received authority to compound an unrestricted formulary under 503A regulations after inspection. A project with the Office of Naval Research demonstrated distributed API manufacturing at cGMP standards and led to DMF filing and ANDA submission to the FDA. No traditional clinical trial results reported.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on On Demand Pharmaceuticals.